Table 3 Antibiotic Susceptibility of clinical P. aeruginosa isolates before and after incubation with Sodium hypochlorite

Meropenem(Carbapenems)

78(65)

8(6.7)

34(28.3)

65(54.2)

15(12.5)

40(33.3)

 < 0.001

Imipenem (Carbapenems)

25(20.8)

40(33.3)

55(45.8)

16(13.3)

40(33.3)

64(53.3)

0.004

Tobramycin(Aminoglycosides)

93(77.5)

3(2.5)

24(20)

83(69.2)

9(7.5)

28(23.3)

0.002

Amikacin (Aminoglycosides)

89(74.2)

11(9.2)

20(16.7)

82(68.3)

12(10)

26(21.7)

0.016

Gentamicin (Aminoglycosides)

91(75.8)

6(5)

23(19.2)

81(67.5)

11(9.2)

28(23.3)

0.002

Cefepime (Cephalosporins)

85(70.8)

14(11.7)

21(17.5)

76(63.3)

18(15)

26(21.7)

0.004

Cefoxitin(Cephalosporins)

0(0)

0(0)

120(100)

0(0)

0(0)

120(100)

-

Ceftazidime (Cephalosporins)

66(55)

26(21.7)

28(23.3)

60(50)

28(23.3)

32(26.7)

0.031

Levofloxacin (Fluoroquinolones)

50(41.7)

30(25)

40(33.3)

44(36.7)

33(27.5)

43(35.8)

 < 0.001

Ciprofloxacin (Fluoroquinolones)

71(59.2)

10(8.3)

39(32.5)

59(49.2)

17(14.2)

44(36.7)

 < 0.001

Piperacillin (Β-Lactam)

93(77.5)

14(11.7)

13(10.8)

93(77.5)

14(11.7)

13(10.8)

1

Piperacillin/Tazobactam

(Beta-Lactamase Inhibitor)

94(78.3)

14(11.7)

12(10)

94(78.3)

14(11.7)

12(10)

1

Ampicillin/Sulbactam

(Beta-Lactamase Inhibitor)

0(0)

0(0)

120(100)

0(0)

0(0)

120(100)

-

Colistin (Polymyxin B)

-

116(96.7)

4(3.3)

-

116(96.7)

4(3.3)

-